# Neovaxsyn Inc.

Canonical: https://abierto.us/vendors/neovaxsyn-inc-ehmtbalckfe8

- UEI: EHMTBALCKFE8
- CAGE: 7RK00
- Location: Ames, IA
- Awards in window: 4 (9 transactions), $2,300,000 obligated, April 17, 2024 to June 25, 2026

## Awarding agencies

- National Institutes of Health: 4 awards, $2,300,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,300,000

## Competition

- Full and Open Competition After Exclusion of Sources: 4 awards

## Solicitations won

- Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 (75N93024C00019), $2,000,000. https://abierto.us/opportunities/75n93024c00019

## Largest awards

- 75N93024C00019 (definitive contract): $2,000,000, National Institutes of Health Niaid. Nanovaccine for Eliciting Bnabs Against HIV-1. https://www.usaspending.gov/award/CONT_AWD_75N93024C00019_7529_-NONE-_-NONE-/
- 75N93024C00050 (definitive contract): $300,000, National Institutes of Health Niaid. Development of a Next-Generation Immunoprevention Platform Against HIV-1. https://www.usaspending.gov/award/CONT_AWD_75N93024C00050_7529_-NONE-_-NONE-/
- 75N93021C00026 (definitive contract): $0, National Institutes of Health Niaid. Nanovaccine for Eliciting 10e8-Like Bnabs Against HIV-1. https://www.usaspending.gov/award/CONT_AWD_75N93021C00026_7529_-NONE-_-NONE-/
- 75N93022C00029 (definitive contract): $0, National Institutes of Health Niaid. SBIR Phase I. https://www.usaspending.gov/award/CONT_AWD_75N93022C00029_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/neovaxsyn-inc-ehmtbalckfe8.